SOSTDC1 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q6X4U4 |
---|---|
Clone Names | 110617124 |
Gene ID | 25928 |
---|---|
Other Names | Sclerostin domain-containing protein 1, Ectodermal BMP inhibitor, Ectodin, Uterine sensitization-associated gene 1 protein, USAG-1, SOSTDC1, USAG1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | SOSTDC1 |
---|---|
Synonyms | USAG1 |
Function | May be involved in the onset of endometrial receptivity for implantation/sensitization for the decidual cell reaction Enhances Wnt signaling and inhibits TGF-beta signaling (By similarity). Directly antagonizes activity of BMP2, BMP4, BMP6 and BMP7 in a dose-dependent manner. |
Cellular Location | Secreted. |
Tissue Location | Highly expressed in kidney and weakly in lung. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene is a member of the sclerostin family and encodesan N-glycosylated, secreted protein with a C-terminal cystineknot-like domain. This protein functions as a bone morphogeneticprotein (BMP) antagonist. Specifically, it directly associates withBMPs, prohibiting them from binding their receptors, therebyregulating BMP signaling during cellular proliferation,differentiation, and programmed cell death.
References
Barber, M.J., et al. PLoS ONE 5 (3), E9763 (2010) :Ohshima, J., et al. Genes Chromosomes Cancer 48(12):1037-1050(2009)Blish, K.R., et al. Mol. Biol. Cell 19(2):457-464(2008)Lamesch, P., et al. Genomics 89(3):307-315(2007)Yanagita, M. Cytokine Growth Factor Rev. 16(3):309-317(2005)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.